Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study

Dr Camille Chakiba - Institute Bergonié, Bordeaux, France
Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study ( Dr Camille Chakiba - Institute Bergonié, Bordeaux, France )
1 Nov 2024

Geriatric interventions are beneficial in reducing treatment-related toxicity in older adults with cancer

Dr Angéline Galvin - Bordeaux Population Health, Bordeaux, France
Geriatric interventions are beneficial in reducing treatment-related toxicity in older adults with cancer ( Dr Angéline Galvin - Bordeaux Population Health, Bordeaux, France )
1 Nov 2024

Unlocking the potential of liquid biopsy applications in personalised care for older adults with cancer

Dr Yue Zhao - University Hospital of Cologne, Cologne, Germany
Unlocking the potential of liquid biopsy applications in personalised care for older adults with cancer ( Dr Yue Zhao - University Hospital of Cologne, Cologne, Germany )
1 Nov 2024

One-year mortality in older adults with breast cancer: prediction using different geriatric tools

Dr Tabassum Wadasadawala and Dr Shivani Sable
One-year mortality in older adults with breast cancer: prediction using different geriatric tools ( Dr Tabassum Wadasadawala and Dr Shivani Sable )
1 Nov 2024

Isa-VRd shows greater efficacy compared to VRd in transplant-ineligible NDMM patients

Prof Meletios Dimopoulos - University of Athens, Athens, Greece
Isa-VRd shows greater efficacy compared to VRd in transplant-ineligible NDMM patients ( Prof Meletios Dimopoulos - University of Athens,  Athens, Greece )
31 Oct 2024

Daratumumab-based maintenance regimens show favourable responses in transplant-eligible NDMM

Prof Meletios Dimopoulos - University of Athens, Athens, Greece
Daratumumab-based maintenance regimens show favourable responses in transplant-eligible NDMM ( Prof Meletios Dimopoulos - University of Athens,  Athens, Greece )
31 Oct 2024

Optimising benefit-risk and minimising impact on quality of life with BCMA-targeting agents in an outpatient setting

Prof Meletios Dimopoulos - University of Athens, Athens, Greece
Optimising benefit-risk and minimising impact on quality of life with BCMA-targeting agents in an outpatient setting ( Prof Meletios Dimopoulos - University of Athens,  Athens, Greece )
31 Oct 2024

Understanding the remaining unmet needs in a post ASCT NDMM setting

Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway
Understanding the remaining unmet needs in a post ASCT NDMM setting ( Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway )
31 Oct 2024

Approaches to risk stratification in high risk myeloma

Dr Irene Ghobrial - Dana-Farber Cancer Institute, Boston, USA
Approaches to risk stratification in high risk myeloma ( Dr Irene Ghobrial - Dana-Farber Cancer Institute, Boston, USA )
31 Oct 2024

Tailored to fit: New approaches in transplant-ineligible NDMM

Prof Xavier Leleu - CHU de Poitiers, Poitiers, France
Tailored to fit: New approaches in transplant-ineligible NDMM ( Prof Xavier Leleu - CHU de Poitiers, Poitiers, France )
30 Oct 2024

Advancements in minimal residual disease detection in myeloma

Dory Abelman, PhD Candidate - University of Toronto, Ontario, Canada
Advancements in minimal residual disease detection in myeloma ( Dory Abelman, PhD Candidate - University of Toronto, Ontario, Canada )
30 Oct 2024

New classification for identifying HR myeloma based on cytogenetic abnormalities

Dr Jill Corre - IUCT Oncopole, Toulouse, France
New classification for identifying HR myeloma based on cytogenetic abnormalities ( Dr Jill Corre - IUCT Oncopole, Toulouse, France )
29 Oct 2024